These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 8840287)
1. Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Hakim RM; Held PJ; Stannard DC; Wolfe RA; Port FK; Daugirdas JT; Agodoa L Kidney Int; 1996 Aug; 50(2):566-70. PubMed ID: 8840287 [TBL] [Abstract][Full Text] [Related]
2. Relationship of dialysis membrane and cause-specific mortality. Bloembergen WE; Hakim RM; Stannard DC; Held PJ; Wolfe RA; Agodoa LY; Port FK Am J Kidney Dis; 1999 Jan; 33(1):1-10. PubMed ID: 9915261 [TBL] [Abstract][Full Text] [Related]
3. The dose of hemodialysis and patient mortality. Held PJ; Port FK; Wolfe RA; Stannard DC; Carroll CE; Daugirdas JT; Bloembergen WE; Greer JW; Hakim RM Kidney Int; 1996 Aug; 50(2):550-6. PubMed ID: 8840285 [TBL] [Abstract][Full Text] [Related]
4. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058 [TBL] [Abstract][Full Text] [Related]
5. Relationship of dose of hemodialysis and cause-specific mortality. Bloembergen WE; Stannard DC; Port FK; Wolfe RA; Pugh JA; Jones CA; Greer JW; Golper TA; Held PJ Kidney Int; 1996 Aug; 50(2):557-65. PubMed ID: 8840286 [TBL] [Abstract][Full Text] [Related]
6. Trends in treatment and survival for hemodialysis patients in the United States. Port FK; Orzol SM; Held PJ; Wolfe RA Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S34-8. PubMed ID: 9892363 [TBL] [Abstract][Full Text] [Related]
8. Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Leypoldt JK; Cheung AK; Carroll CE; Stannard DC; Pereira BJ; Agodoa LY; Port FK Am J Kidney Dis; 1999 Feb; 33(2):349-55. PubMed ID: 10023649 [TBL] [Abstract][Full Text] [Related]
9. Dialysis membranes for blood purification. Sakai K Front Med Biol Eng; 2000; 10(2):117-29. PubMed ID: 10898241 [TBL] [Abstract][Full Text] [Related]
10. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis. de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797 [TBL] [Abstract][Full Text] [Related]
11. The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients. Van Stone JC ASAIO J; 1995; 41(3):M713-6. PubMed ID: 8573899 [TBL] [Abstract][Full Text] [Related]
12. Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry. Abe M; Hamano T; Wada A; Nakai S; Masakane I; PLoS One; 2017; 12(9):e0184424. PubMed ID: 28910324 [TBL] [Abstract][Full Text] [Related]
13. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL; Vincent JL; Tielemans C Nephrol Dial Transplant; 2000 Feb; 15(2):224-30. PubMed ID: 10648669 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the impact of high-flux dialysis on mortality in hemodialysis patients with and without residual renal function. Kim HW; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK PLoS One; 2014; 9(6):e97184. PubMed ID: 24906205 [TBL] [Abstract][Full Text] [Related]
15. Epoetin requirement does not depend on dialysis dose when Kt/N > 1.33 in patients on regular dialysis treatment with cellulosic membranes and adequate iron stores. Movilli E; Cancarini GC; Vizzardi V; Camerini C; Brunori G; Cassamali S; Maiorca R J Nephrol; 2003; 16(4):546-51. PubMed ID: 14696757 [TBL] [Abstract][Full Text] [Related]
16. Mortality and duration of hemodialysis treatment. Held PJ; Levin NW; Bovbjerg RR; Pauly MV; Diamond LH JAMA; 1991 Feb; 265(7):871-5. PubMed ID: 1899455 [TBL] [Abstract][Full Text] [Related]
17. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study. Port FK; Wolfe RA; Hulbert-Shearon TE; Daugirdas JT; Agodoa LY; Jones C; Orzol SM; Held PJ Am J Kidney Dis; 2001 Feb; 37(2):276-86. PubMed ID: 11157367 [TBL] [Abstract][Full Text] [Related]
18. Body size, dose of hemodialysis, and mortality. Wolfe RA; Ashby VB; Daugirdas JT; Agodoa LY; Jones CA; Port FK Am J Kidney Dis; 2000 Jan; 35(1):80-8. PubMed ID: 10620548 [TBL] [Abstract][Full Text] [Related]
19. Influence of the dialysis membrane on outcome of ESRD patients. Hakim RM Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S71-5. PubMed ID: 9892369 [TBL] [Abstract][Full Text] [Related]
20. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Abbott KC; Glanton CW; Trespalacios FC; Oliver DK; Ortiz MI; Agodoa LY; Cruess DF; Kimmel PL Kidney Int; 2004 Feb; 65(2):597-605. PubMed ID: 14717930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]